Eton Pharmaceuticals (ETON) Current Assets (2017 - 2026)

Eton Pharmaceuticals has disclosed Current Assets across 10 years of filings, most recently posting $68.6 million for Q2 2026.

• In Q2 2026, Current Assets changed 0.23% year-over-year to $68.6 million; the TTM figure through Jun 2026 stood at $68.6 million (changed 0.23% YoY), while the FY2025 annual figure was $60.6 million, up 47.68% from the prior year.
• Current Assets came in at $68.6 million for Q2 2026 at Eton Pharmaceuticals, up from $60.6 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $72.0 million in Q3 2025 to a low of $16.4 million in Q3 2022.
• Average Current Assets over 5 years is $36.1 million, with a median of $26.8 million recorded in 2023.
• Year-over-year, Current Assets tumbled 38.06% in 2022 and jumped 169.1% in 2025.
• Over 5 years, Current Assets stood at $20.0 million in 2022, then jumped by 34.17% to $26.8 million in 2023, then jumped by 52.84% to $41.0 million in 2024, then soared by 47.68% to $60.6 million in 2025, then advanced by 13.24% to $68.6 million in 2026.
• Per Business Quant data, the three most recent Current Assets figures were $68.6 million in Q2 2026, $60.6 million in Q4 2025, and $72.0 million in Q3 2025.